{"id":29672,"date":"2026-03-11T11:18:45","date_gmt":"2026-03-11T11:18:45","guid":{"rendered":"https:\/\/itbusinesstoday.com\/?p=29672"},"modified":"2026-03-11T11:18:45","modified_gmt":"2026-03-11T11:18:45","slug":"curatis-transfers-corticorelin-japan-rights-to-neupharma","status":"publish","type":"post","link":"https:\/\/itbusinesstoday.com\/ja\/health-tech\/pharma\/curatis-transfers-corticorelin-japan-rights-to-neupharma\/","title":{"rendered":"\u30ad\u30e5\u30e9\u30c6\u30a3\u30b9\u793e\u3001\u30b3\u30eb\u30c1\u30b3\u30ec\u30ea\u30f3\u306e\u65e5\u672c\u306b\u304a\u3051\u308b\u6a29\u5229\u3092\u30cb\u30e5\u30fc\u30d5\u30a1\u30fc\u30de\u793e\u306b\u8b72\u6e21"},"content":{"rendered":"

\u30ad\u30e5\u30e9\u30c6\u30a3\u30b9\u30fb\u30db\u30fc\u30eb\u30c7\u30a3\u30f3\u30b0\u682a\u5f0f\u4f1a\u793e\u306f\u3001\u65e5\u672c\u306e\u88fd\u85ac\u4f1a\u793e\u3067\u3042\u308b\u30ce\u30a4\u30d5\u30a1\u30fc\u30de\u682a\u5f0f\u4f1a\u793e\u3068\u3001C-PTBE-01\u3068\u3057\u3066\u77e5\u3089\u308c\u308b\u30b3\u30eb\u30c1\u30b3\u30ec\u30ea\u30f3\u306b\u95a2\u3059\u308b\u72ec\u5360\u7684\u30e9\u30a4\u30bb\u30f3\u30b9\u304a\u3088\u3073\u958b\u767a\u5951\u7d04\u3092\u7de0\u7d50\u3057\u307e\u3057\u305f\u3002\u672c\u7814\u7a76\u306f\u3001\u8133\u816b\u760d\u60a3\u8005\u306b\u751f\u3058\u308b\u816b\u760d\u5468\u56f2\u8133\u6d6e\u816b\u306e\u6cbb\u7642\u6cd5\u3092\u691c\u8a0e\u3059\u308b\u3082\u306e\u3067\u3059\u3002\u65e5\u672c\u306e\u88fd\u85ac\u696d\u754c\u306f\u3001\u7c73\u56fd\u3001\u6b27\u5dde\u306b\u6b21\u3044\u3067\u4e16\u754c\u7b2c3\u4f4d\u306e\u5e02\u5834\u898f\u6a21\u3092\u8a87\u3063\u3066\u304a\u308a\u3001\u672c\u85ac\u3092\u4e3b\u8981\u5e02\u5834\u306b\u5c0e\u5165\u3059\u308b\u305f\u3081\u306b\u306f\u3001\u3053\u306e\u63d0\u643a\u304c\u4e0d\u53ef\u6b20\u3067\u3059\u3002.<\/p>

\u3053\u306e\u5951\u7d04\u3067\u306f, Neupharma<\/a> \u306f\u3001\u65e5\u672c\u306b\u304a\u3051\u308b\u30b3\u30eb\u30c1\u30b3\u30ec\u30ea\u30f3\u306e\u72ec\u5360\u7684\u958b\u767a\u30fb\u8ca9\u58f2\u6a29\u3092\u53d6\u5f97\u3057\u307e\u3059\u3002\u540c\u793e\u306f\u307e\u305f\u3001\u85ac\u4e8b\u627f\u8a8d\u306b\u5fc5\u8981\u306a\u65e5\u672c\u3067\u306e\u6975\u3081\u3066\u91cd\u8981\u306a\u81e8\u5e8a\u8a66\u9a13\u306e\u8cc7\u91d1\u8abf\u9054\u3068\u5b9f\u65bd\u3082\u62c5\u5f53\u3057\u307e\u3059\u3002\u30ad\u30e5\u30e9\u30c6\u30a3\u30b9\u793e\u306f\u3001\u5951\u7d04\u4e00\u6642\u91d1\u304a\u3088\u3073\u85ac\u4e8b\u30fb\u5546\u696d\u4e0a\u306e\u9032\u6357\u306b\u5fdc\u3058\u305f\u30de\u30a4\u30eb\u30b9\u30c8\u30f3\u3092\u53d7\u3051\u53d6\u308a\u307e\u3059\u3002\u3053\u308c\u3089\u306e\u76ee\u6a19\u304c\u3059\u3079\u3066\u9054\u6210\u3055\u308c\u305f\u5834\u5408\u3001\u652f\u6255\u984d\u306f\u6700\u59278350\u4e07\u30b9\u30a4\u30b9\u30d5\u30e9\u30f3\u306b\u9054\u3057\u307e\u3059\u3002\u305d\u306e\u4e0a\u3001\u30ad\u30e5\u30e9\u30c6\u30a3\u30b9\u306f\u65e5\u672c\u3067\u306e\u58f2\u4e0a\u306b\u5bfe\u3057\u3066\u6700\u592720\uff05\u306e\u30ed\u30a4\u30e4\u30eb\u30c6\u30a3\u3092\u53d7\u3051\u53d6\u308a\u307e\u3059\u3002.<\/p>

The current plan is to introduce corticorelin in Japan first for children and adolescents. A meeting with Japan’s drug regulator PMDA is expected in the summer of 2026 to discuss the study required for registration. If things move as expected, the clinical trial in Japan should begin in 2027.<\/p>

\u3053\u3061\u3089\u3082\u304a\u8aad\u307f\u304f\u3060\u3055\u3044\uff1a \u65e5\u7acb\u3068\u5869\u91ce\u7fa9\u88fd\u85ac\u3001\u85ac\u4e8b\u696d\u52d9\u306bgenAI\u3092\u5c0e\u5165<\/a><\/h4>

\u540c\u793e\u306f\u3001\u73fe\u5728\u306e\u4f5c\u696d\u3092\u7d99\u7d9a\u3057\u306a\u304c\u3089\u3001\u30d7\u30ed\u30b0\u30e9\u30e0\u5168\u4f53\u306e\u4f5c\u696d\u3092\u884c\u3063\u3066\u3044\u307e\u3059\u3002\u540c\u793e\u306f\u3001\u56fd\u969b\u7684\u306a\u63d0\u643a\u4ea4\u6e09\u3092\u78ba\u7acb\u3059\u308b\u4e00\u65b9\u3067\u3001\u7c73\u56fd\u304a\u3088\u3073\u6b27\u5dde\u9023\u5408\uff08EU\uff09\u306e\u627f\u8a8d\u3092\u6c42\u3081\u308b\u5fc5\u9808\u306e\u7b2c3\u76f8\u8a66\u9a13\u306e\u6e96\u5099\u3092\u9032\u3081\u3066\u3044\u307e\u3059\u3002.<\/p>

\u30b3\u30eb\u30c1\u30b3\u30ec\u30ea\u30f3\u306f Curatis<\/a>’ lead product candidate. It is being developed for peritumoral brain edema, often called PTBE. This condition appears alongside many primary and metastatic brain tumors. Metastases from lung cancer, breast cancer, melanoma, and colorectal cancer are common sources.<\/p>

PTBE\u306f\u3001\u8133\u816b\u760d\u306e\u5468\u56f2\u306b\u4f53\u6db2\u304c\u305f\u307e\u308b\u3068\u767a\u75c7\u3057\u307e\u3059\u3002\u305d\u306e\u5727\u529b\u304c\u8133\u306e\u6a5f\u80fd\u3092\u59a8\u3052\u307e\u3059\u3002\u60a3\u8005\u306f\u3001\u982d\u75db\u3084\u5614\u5410\u3001\u9ebb\u75fa\u3084\u8a00\u8a9e\u969c\u5bb3\u3001\u8996\u529b\u969c\u5bb3\u3001\u7cbe\u795e\u72b6\u614b\u306e\u5909\u5316\u306a\u3069\u306e\u795e\u7d4c\u5b66\u7684\u554f\u984c\u3092\u542b\u3080\u8907\u6570\u306e\u75c7\u72b6\u3092\u7d4c\u9a13\u3057\u307e\u3059\u3002.<\/p>

\u4eca\u306e\u3068\u3053\u308d\u3001\u901a\u5e38\u306e\u6cbb\u7642\u306f\u30b3\u30eb\u30c1\u30b3\u30b9\u30c6\u30ed\u30a4\u30c9\u306b\u983c\u3063\u3066\u3044\u307e\u3059\u3002\u30b9\u30c6\u30ed\u30a4\u30c9\u306f\u816b\u308c\u3092\u6291\u3048\u307e\u3059\u304c\u3001\u526f\u4f5c\u7528\u306f\u6df1\u523b\u3067\u3059\u3002\u3053\u306e\u75be\u60a3\u306e\u60a3\u8005\u306f\u3001\u91cd\u5ea6\u306e\u30df\u30aa\u30d1\u30c1\u30fc\u3001\u7cd6\u4ee3\u8b1d\u306e\u554f\u984c\u3001\u7b4b\u8089\u306e\u8870\u3048\u3001\u4f53\u91cd\u306e\u7570\u5e38\u5897\u52a0\u3001\u9aa8\u7c97\u3057\u3087\u3046\u75c7\u3001\u80c3\u708e\u3001\u6d88\u5316\u7ba1\u51fa\u8840\u3001\u9ad8\u8840\u5727\u3001\u6027\u683c\u306e\u5909\u5316\u306a\u3069\u3001\u8907\u6570\u306e\u5065\u5eb7\u554f\u984c\u3092\u7d4c\u9a13\u3057\u307e\u3059\u3002\u30b9\u30c6\u30ed\u30a4\u30c9\u306e\u4f7f\u7528\u306f\u3001\u9069\u5207\u306aT\u7d30\u80de\u6a5f\u80fd\u3092\u5fc5\u8981\u3068\u3059\u308b\u5316\u5b66\u7642\u6cd5\u3084\u6700\u65b0\u306e\u514d\u75ab\u7642\u6cd5\u3092\u542b\u3080\u69d8\u3005\u306a\u304c\u3093\u6cbb\u7642\u306b\u652f\u969c\u3092\u304d\u305f\u3057\u307e\u3059\u3002.<\/p>

\u30b3\u30eb\u30c1\u30b3\u30ec\u30ea\u30f3\u306f41\u30a2\u30df\u30ce\u9178\u306e\u5185\u56e0\u6027\u30dd\u30ea\u30da\u30d7\u30c1\u30c9\u3067\u3059\u3002\u524d\u81e8\u5e8a\u7814\u7a76\u3067\u306f\u3001\u30b3\u30eb\u30c1\u30b3\u30ec\u30ea\u30f3\u306f\u60aa\u6027\u816b\u760d\u306b\u3088\u3063\u3066\u7834\u58ca\u3055\u308c\u305f\u8840\u6db2\u8133\u95a2\u9580\u3092\u5b89\u5b9a\u5316\u3055\u305b\u308b\u50cd\u304d\u304c\u3042\u308b\u3053\u3068\u304c\u793a\u3055\u308c\u3066\u3044\u307e\u3059\u3002PTBE\u60a3\u8005\u3092\u5bfe\u8c61\u3068\u3057\u305f2\u3064\u306e\u81e8\u5e8a\u7814\u7a76\u3067\u306f\u3001\u30b3\u30eb\u30c1\u30b3\u30ec\u30ea\u30f3\u304c\u30b9\u30c6\u30ed\u30a4\u30c9\u306e\u5fc5\u8981\u6027\u3092\u5927\u5e45\u306b\u6e1b\u3089\u3057\u3001\u5834\u5408\u306b\u3088\u3063\u3066\u306f\u30b9\u30c6\u30ed\u30a4\u30c9\u306b\u53d6\u3063\u3066\u4ee3\u308f\u308b\u53ef\u80fd\u6027\u3055\u3048\u3042\u308b\u3053\u3068\u304c\u3059\u3067\u306b\u793a\u5506\u3055\u308c\u3066\u3044\u307e\u3059\u3002.<\/p>

\u60a3\u8005\u6570\u304c\u591a\u3044\u306e\u3067\u3001\u30c1\u30e3\u30f3\u30b9\u306f\u304b\u306a\u308a\u5927\u304d\u3044\u3002\u65e5\u672c\u3067\u306f\u7d046\u4e07\u4eba\u3001\u4e16\u754c\u3067\u306f\u7d0450\u4e07\u4eba\u306e\u60a3\u8005\u304c\u30b3\u30eb\u30c1\u30b3\u30ec\u30ea\u30f3\u6cbb\u7642\u306e\u5bfe\u8c61\u3068\u306a\u308b\u3068\u63a8\u5b9a\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u4e16\u754c\u306e\u5e02\u5834\u898f\u6a21\u306f\u5e74\u959310\u5104\u7c73\u30c9\u30eb\u3092\u8d85\u3048\u308b\u3068\u4e88\u60f3\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u73fe\u5728\u3001\u30b3\u30eb\u30c1\u30b3\u30ec\u30ea\u30f3\u306f\u307e\u3060\u6cbb\u9a13\u85ac\u3067\u3042\u308a\u3001\u7c73\u56fd\u5185\u5916\u3067\u6cbb\u7642\u85ac\u3068\u3057\u3066\u627f\u8a8d\u3055\u308c\u3066\u3044\u307e\u305b\u3093\u3002.<\/p>","protected":false},"excerpt":{"rendered":"

Curatis Holding AG has signed an exclusive licensing and development agreement with Japanese pharma company Neupharma for corticorelin, also known as C-PTBE-01. The research examines how to treat peritumoral brain edema which occurs in patients with brain tumors. The pharmaceutical industry of Japan ranks as the third largest market in the world after the United States and Europe which makes this partnership essential for introducing the drug to a major market.Under the agreement, Neupharma gets the exclusive rights to develop and commercialize corticorelin in Japan. The company will also take charge of financing and running the pivotal clinical trial in the country that is required for regulatory approval. Curatis will […]<\/p>\n","protected":false},"author":7,"featured_media":29673,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_bbp_topic_count":0,"_bbp_reply_count":0,"_bbp_total_topic_count":0,"_bbp_total_reply_count":0,"_bbp_voice_count":0,"_bbp_anonymous_reply_count":0,"_bbp_topic_count_hidden":0,"_bbp_reply_count_hidden":0,"_bbp_forum_subforum_count":0,"wprm-recipe-roundup-name":"","wprm-recipe-roundup-description":"","postBodyCss":"","postBodyMargin":[],"postBodyPadding":[],"postBodyBackground":{"backgroundType":"classic","gradient":""},"footnotes":""},"categories":[89,207,237,182],"tags":[11874,11873,11872,424,11875],"ppma_author":[572],"class_list":["post-29672","post","type-post","status-publish","format-standard","has-post-thumbnail","category-health-tech","category-international","category-news","category-pharma","tag-curatis-holding","tag-neupharma","tag-peritumoral-brain-edema","tag-pharma","tag-pulmonology"],"yoast_head":"\nCuratis Grants Japan Corticorelin Rights to Neupharma<\/title>\n<meta name=\"description\" content=\"Curatis with Neupharma to license corticorelin in Japan, targeting peritumoral brain edema and entering one of the largest pharma markets.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/itbusinesstoday.com\/ja\/health-tech\/pharma\/curatis-transfers-corticorelin-japan-rights-to-neupharma\/\" \/>\n<meta property=\"og:locale\" content=\"ja_JP\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Curatis Grants Japan Corticorelin Rights to Neupharma\" \/>\n<meta property=\"og:description\" content=\"Curatis with Neupharma to license corticorelin in Japan, targeting peritumoral brain edema and entering one of the largest pharma markets.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/itbusinesstoday.com\/ja\/health-tech\/pharma\/curatis-transfers-corticorelin-japan-rights-to-neupharma\/\" \/>\n<meta property=\"og:site_name\" content=\"itbusinesstoday\" \/>\n<meta property=\"article:published_time\" content=\"2026-03-11T11:18:45+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2026\/03\/Curatis-and-Neupharma-Announce-Exclusive-Licensing-Agreement-to-Develop-and-Market-Corticorelin-C-PTBE-01-for-the-Treatment-of-Peritumoral-Brain-Edema-in-Japan.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"800\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"ITBT StaffWriter\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u57f7\u7b46\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"ITBT StaffWriter\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593\" \/>\n\t<meta name=\"twitter:data2\" content=\"3\u5206\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u30ad\u30e5\u30e9\u30c6\u30a3\u30b9\u793e\u3001\u65e5\u672c\u306b\u304a\u3051\u308b\u30b3\u30eb\u30c1\u30b3\u30ec\u30ea\u30f3\u306e\u6a29\u5229\u3092\u30cb\u30e5\u30fc\u30d5\u30a1\u30fc\u30de\u793e\u306b\u8a31\u8afe","description":"\u30ad\u30e5\u30e9\u30c6\u30a3\u30b9\u306f\u30ce\u30a4\u30d5\u30a1\u30fc\u30de\u3068\u63d0\u643a\u3057\u3001\u816b\u760d\u5468\u56f2\u306e\u8133\u6d6e\u816b\u3092\u6a19\u7684\u3068\u3057\u305f\u30b3\u30eb\u30c1\u30b3\u30ec\u30ea\u30f3\u306e\u65e5\u672c\u306b\u304a\u3051\u308b\u30e9\u30a4\u30bb\u30f3\u30b9\u5951\u7d04\u3092\u7de0\u7d50\u3057\u3001\u4e16\u754c\u6700\u5927\u7d1a\u306e\u533b\u85ac\u54c1\u5e02\u5834\u306e\u4e00\u3064\u3078\u306e\u53c2\u5165\u3092\u76ee\u6307\u3057\u3066\u3044\u307e\u3059\u3002.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/itbusinesstoday.com\/ja\/health-tech\/pharma\/curatis-transfers-corticorelin-japan-rights-to-neupharma\/","og_locale":"ja_JP","og_type":"article","og_title":"Curatis Grants Japan Corticorelin Rights to Neupharma","og_description":"Curatis with Neupharma to license corticorelin in Japan, targeting peritumoral brain edema and entering one of the largest pharma markets.","og_url":"https:\/\/itbusinesstoday.com\/ja\/health-tech\/pharma\/curatis-transfers-corticorelin-japan-rights-to-neupharma\/","og_site_name":"itbusinesstoday","article_published_time":"2026-03-11T11:18:45+00:00","og_image":[{"width":1200,"height":800,"url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2026\/03\/Curatis-and-Neupharma-Announce-Exclusive-Licensing-Agreement-to-Develop-and-Market-Corticorelin-C-PTBE-01-for-the-Treatment-of-Peritumoral-Brain-Edema-in-Japan.webp","type":"image\/webp"}],"author":"ITBT StaffWriter","twitter_card":"summary_large_image","twitter_misc":{"\u57f7\u7b46\u8005":"ITBT StaffWriter","\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593":"3\u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/curatis-transfers-corticorelin-japan-rights-to-neupharma\/#article","isPartOf":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/curatis-transfers-corticorelin-japan-rights-to-neupharma\/"},"author":{"name":"ITBT StaffWriter","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/person\/94fb575e469aff25a4b938814d050f15"},"headline":"Curatis Transfers Corticorelin Japan Rights to Neupharma","datePublished":"2026-03-11T11:18:45+00:00","mainEntityOfPage":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/curatis-transfers-corticorelin-japan-rights-to-neupharma\/"},"wordCount":516,"publisher":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#organization"},"image":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/curatis-transfers-corticorelin-japan-rights-to-neupharma\/#primaryimage"},"thumbnailUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2026\/03\/Curatis-and-Neupharma-Announce-Exclusive-Licensing-Agreement-to-Develop-and-Market-Corticorelin-C-PTBE-01-for-the-Treatment-of-Peritumoral-Brain-Edema-in-Japan.webp","keywords":["Curatis Holding","Neupharma","peritumoral brain edema","Pharma","pulmonology"],"articleSection":["Health Tech","International","News","Pharma"],"inLanguage":"ja"},{"@type":"WebPage","@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/curatis-transfers-corticorelin-japan-rights-to-neupharma\/","url":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/curatis-transfers-corticorelin-japan-rights-to-neupharma\/","name":"\u30ad\u30e5\u30e9\u30c6\u30a3\u30b9\u793e\u3001\u65e5\u672c\u306b\u304a\u3051\u308b\u30b3\u30eb\u30c1\u30b3\u30ec\u30ea\u30f3\u306e\u6a29\u5229\u3092\u30cb\u30e5\u30fc\u30d5\u30a1\u30fc\u30de\u793e\u306b\u8a31\u8afe","isPartOf":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#website"},"primaryImageOfPage":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/curatis-transfers-corticorelin-japan-rights-to-neupharma\/#primaryimage"},"image":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/curatis-transfers-corticorelin-japan-rights-to-neupharma\/#primaryimage"},"thumbnailUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2026\/03\/Curatis-and-Neupharma-Announce-Exclusive-Licensing-Agreement-to-Develop-and-Market-Corticorelin-C-PTBE-01-for-the-Treatment-of-Peritumoral-Brain-Edema-in-Japan.webp","datePublished":"2026-03-11T11:18:45+00:00","description":"\u30ad\u30e5\u30e9\u30c6\u30a3\u30b9\u306f\u30ce\u30a4\u30d5\u30a1\u30fc\u30de\u3068\u63d0\u643a\u3057\u3001\u816b\u760d\u5468\u56f2\u306e\u8133\u6d6e\u816b\u3092\u6a19\u7684\u3068\u3057\u305f\u30b3\u30eb\u30c1\u30b3\u30ec\u30ea\u30f3\u306e\u65e5\u672c\u306b\u304a\u3051\u308b\u30e9\u30a4\u30bb\u30f3\u30b9\u5951\u7d04\u3092\u7de0\u7d50\u3057\u3001\u4e16\u754c\u6700\u5927\u7d1a\u306e\u533b\u85ac\u54c1\u5e02\u5834\u306e\u4e00\u3064\u3078\u306e\u53c2\u5165\u3092\u76ee\u6307\u3057\u3066\u3044\u307e\u3059\u3002.","breadcrumb":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/curatis-transfers-corticorelin-japan-rights-to-neupharma\/#breadcrumb"},"inLanguage":"ja","potentialAction":[{"@type":"ReadAction","target":["https:\/\/itbusinesstoday.com\/health-tech\/pharma\/curatis-transfers-corticorelin-japan-rights-to-neupharma\/"]}]},{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/curatis-transfers-corticorelin-japan-rights-to-neupharma\/#primaryimage","url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2026\/03\/Curatis-and-Neupharma-Announce-Exclusive-Licensing-Agreement-to-Develop-and-Market-Corticorelin-C-PTBE-01-for-the-Treatment-of-Peritumoral-Brain-Edema-in-Japan.webp","contentUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2026\/03\/Curatis-and-Neupharma-Announce-Exclusive-Licensing-Agreement-to-Develop-and-Market-Corticorelin-C-PTBE-01-for-the-Treatment-of-Peritumoral-Brain-Edema-in-Japan.webp","width":1200,"height":800,"caption":"Curatis Holding"},{"@type":"BreadcrumbList","@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/curatis-transfers-corticorelin-japan-rights-to-neupharma\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/itbusinesstoday.com\/"},{"@type":"ListItem","position":2,"name":"Curatis Transfers Corticorelin Japan Rights to Neupharma"}]},{"@type":"WebSite","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#website","url":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/","name":"\u30a4\u30c3\u30c8\u30d3\u30b8\u30cd\u30b9\u30c8\u30a5\u30c7\u30a4","description":"","publisher":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ja"},{"@type":"Organization","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#organization","name":"\u30a4\u30c3\u30c8\u30d3\u30b8\u30cd\u30b9\u30c8\u30a5\u30c7\u30a4","url":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/","logo":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/logo\/image\/","url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Asset-1.png","contentUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Asset-1.png","width":663,"height":275,"caption":"itbusinesstoday"},"image":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/person\/94fb575e469aff25a4b938814d050f15","name":"ITBT\u30b9\u30bf\u30c3\u30d5\u30e9\u30a4\u30bf\u30fc","image":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Favicon-1.png90b3cb23d1d9c08733d969d29ea2d30d","url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Favicon-1.png","contentUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Favicon-1.png","caption":"ITBT StaffWriter"},"description":"ITBT\u30b9\u30bf\u30c3\u30d5\u30e9\u30a4\u30bf\u30fc\u306f\u3001IT Business Today\u306e\u793e\u5185\u5bc4\u7a3f\u8005\u3067\u3001\u30bf\u30a4\u30e0\u30ea\u30fc\u306a\u30cb\u30e5\u30fc\u30b9\u3068QuickBytes\u306e\u914d\u4fe1\u3092\u62c5\u5f53\u3057\u3066\u3044\u307e\u3059\u3002IT\u3001\u30cf\u30a4\u30c6\u30af\u3001\u4f01\u696d\u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3\u306e\u6700\u65b0\u52d5\u5411\u3092\u30ab\u30d0\u30fc\u3057\u3001\u7c21\u6f54\u3067\u30a4\u30f3\u30d1\u30af\u30c8\u306e\u3042\u308b\u6700\u65b0\u60c5\u5831\u3092\u8aad\u8005\u306b\u63d0\u4f9b\u3057\u3066\u3044\u307e\u3059\u3002","sameAs":["https:\/\/itbusinesstoday.com\/"],"url":"https:\/\/itbusinesstoday.com\/ja\/author\/itbt-staffwriter\/"}]}},"authors":[{"term_id":572,"user_id":7,"is_guest":0,"slug":"itbt-staffwriter","display_name":"ITBT StaffWriter","avatar_url":{"url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Favicon-1.png","url2x":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Favicon-1.png"},"author_category":"","first_name":"ITBT","last_name":"StaffWriter","user_url":"https:\/\/itbusinesstoday.com\/","job_title":"","description":"ITBT\u30b9\u30bf\u30c3\u30d5\u30e9\u30a4\u30bf\u30fc\u306f\u3001IT Business Today\u306e\u793e\u5185\u5bc4\u7a3f\u8005\u3067\u3001\u30bf\u30a4\u30e0\u30ea\u30fc\u306a\u30cb\u30e5\u30fc\u30b9\u3068QuickBytes\u306e\u914d\u4fe1\u3092\u62c5\u5f53\u3057\u3066\u3044\u307e\u3059\u3002IT\u3001\u30cf\u30a4\u30c6\u30af\u3001\u4f01\u696d\u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3\u306e\u6700\u65b0\u52d5\u5411\u3092\u30ab\u30d0\u30fc\u3057\u3001\u7c21\u6f54\u3067\u30a4\u30f3\u30d1\u30af\u30c8\u306e\u3042\u308b\u6700\u65b0\u60c5\u5831\u3092\u8aad\u8005\u306b\u63d0\u4f9b\u3057\u3066\u3044\u307e\u3059\u3002"}],"_links":{"self":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts\/29672","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/comments?post=29672"}],"version-history":[{"count":1,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts\/29672\/revisions"}],"predecessor-version":[{"id":29674,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts\/29672\/revisions\/29674"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/media\/29673"}],"wp:attachment":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/media?parent=29672"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/categories?post=29672"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/tags?post=29672"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/ppma_author?post=29672"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}